Results
|
|
7121.
|
|
|
|
7122.
|
|
|
|
7123.
|
|
|
|
7124.
|
|
|
|
7125.
|
|
|
|
7126.
|
|
|
|
7127.
|
|
|
|
7128.
|
|
|
|
7129.
|
|
|
|
7130.
|
|
|
|
7131.
|
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study. [electronic resource] by
- Molife, L R
- Fong, P C
- Paccagnella, L
- Reid, A H M
- Shaw, H M
- Vidal, L
- Arkenau, H-T
- Karavasilis, V
- Yap, T A
- Olmos, D
- Spicer, J
- Postel-Vinay, S
- Yin, D
- Lipton, A
- Demers, L
- Leitzel, K
- Gualberto, A
- de Bono, J S
Producer: 20100916
In:
British journal of cancer vol. 103
Availability: No items available.
|
|
|
7132.
|
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer. [electronic resource] by
- Miles, David W
- Chan, Arlene
- Dirix, Luc Y
- Cortés, Javier
- Pivot, Xavier
- Tomczak, Piotr
- Delozier, Thierry
- Sohn, Joo Hyuk
- Provencher, Louise
- Puglisi, Fabio
- Harbeck, Nadia
- Steger, Guenther G
- Schneeweiss, Andreas
- Wardley, Andrew M
- Chlistalla, Andreas
- Romieu, Gilles
Producer: 20100720
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|
|
|
7133.
|
|
|
|
7134.
|
|
|
|
7135.
|
Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer. [electronic resource] by
- Nakamura, Seigo
- Ando, Masashi
- Masuda, Norikazu
- Aogi, Kenjiro
- Ino, Hiroyo
- Iwata, Hiroji
- Tokuda, Yutaka
- Yamamoto, Naohito
- Kasai, Hiroi
- Takeuchi, Masahiko
- Tsuda, Hitoshi
- Akiyama, Futoshi
- Kurosumi, Masafumi
- Fujiwara, Yasuhiro
Producer: 20120309
In:
Clinical breast cancer vol. 12
Availability: No items available.
|
|
|
7136.
|
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer. [electronic resource] by
- Fleming, Mark T
- Sonpavde, Guru
- Kolodziej, Michael
- Awasthi, Sanjay
- Hutson, Thomas E
- Martincic, Danko
- Rastogi, Ashutosh
- Rousey, Steven R
- Weinstein, Ralph E
- Galsky, Matthew D
- Berry, William R
- Wang, Yunfei
- Boehm, Kristi A
- Asmar, Lina
- Rauch, Mary A
- Beer, Tomasz M
Producer: 20120621
In:
Clinical genitourinary cancer vol. 10
Availability: No items available.
|
|
|
7137.
|
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models. [electronic resource] by
- Proia, David A
- Sang, Jim
- He, Suqin
- Smith, Donald L
- Sequeira, Manuel
- Zhang, Chaohua
- Liu, Yuan
- Ye, Shuxia
- Zhou, Dan
- Blackman, Ronald K
- Foley, Kevin P
- Koya, Keizo
- Wada, Yumiko
Producer: 20130404
In:
Investigational new drugs vol. 30
Availability: No items available.
|
|
|
7138.
|
Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: a randomized, open-label study. [electronic resource] by
- Sun, Y
- Wu, Y-L
- Zhou, C-C
- Zhang, L
- Zhang, L
- Liu, X-Y
- Yu, S-Y
- Jiang, G-L
- Li, K
- Qin, S-K
- Ma, S-L
- Han, L
- Quinlivan, M
- Orlando, M
- Zhang, X-Q
Producer: 20130712
In:
Lung cancer (Amsterdam, Netherlands) vol. 79
Availability: No items available.
|
|
|
7139.
|
|
|
|
7140.
|
|